Papers
1
Total Citations
48
H-Index
1
About
Shi‐Ming Tu is a leading urologic oncologist whose research centers on the surgical management of testicular and genitourinary cancers, with a particular focus on robotic and minimally invasive techniques. His most notable contribution is his pioneering work on robotic postchemotherapy retroperitoneal lymph node dissection (RPC-RPLND) for testicular cancer, a technically demanding procedure that offers patients reduced morbidity while maintaining oncologic rigor. His 2019 paper on this topic, with 48 citations, has become a foundational reference in the field, demonstrating that robotic approaches can be safely applied even in the challenging postchemotherapy setting. Beyond this landmark study, Tu has advanced the understanding of nerve-sparing techniques and perioperative outcomes in RPLND, helping to shift the standard of care toward less invasive options. His work has been instrumental in training a generation of surgeons, and he is frequently invited to lecture at international conferences. With a career dedicated to improving survival and quality of life for young men with testicular cancer, Tu’s research continues to shape the intersection of robotics and complex oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1